Information for "APPRAISE-1"
Jump to navigation
Jump to search
Basic information
| Display title | APPRAISE-1 |
| Redirects to | Safety Of The Factor Xa Inhibitor, Apixaban, In Combination With Antiplatelet Therapy After Acute Coronary Syndromes: A Dose-Guiding Trial (info) |
| Default sort key | APPRAISE-1 |
| Page length (in bytes) | 152 |
| Namespace ID | 0 |
| Page ID | 172862 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Number of subpages of this page | 0 (0 redirects; 0 non-redirects) |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Michaelagibson (talk | contribs) |
| Date of page creation | 01:03, 29 June 2009 |
| Latest editor | Michaelagibson (talk | contribs) |
| Date of latest edit | 01:03, 29 June 2009 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 30 days) | 0 |
| Recent number of distinct authors | 0 |